| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |